Cardiometabolic biomarkers in women with polycystic ovary syndrome.

Kim van der Ham, Yvonne V Louwers, Joop S E Laven

Fertility and sterility 2022 May

filter terms:

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. Apart from the reproductive problems, PCOS is also associated with metabolic disturbances, and therefore, it also affects adolescents and postmenopausal women with PCOS as well as their offspring and other first-degree relatives. Adolescents with PCOS show unfavorable cardiometabolic biomarkers more often than controls, such as overweight/obesity and hyperandrogenism, and studies also suggest an unfavorable lipid profile. During reproductive age, women with PCOS develop additional cardiometabolic biomarkers, such as hypertension, insulin resistance, and metabolic syndrome. Growing evidence also supports the important role of inflammatory cytokines in cardiovascular health in these women. During menopausal transition, some PCOS characteristics ameliorate, whereas other biomarkers increase, such as body mass index, insulin resistance, type 2 diabetes, and hypertension. Offspring of women with PCOS have a lower birth weight and a higher body mass index later in life than controls. In addition, fathers, mothers, and siblings of women with PCOS show unfavorable cardiometabolic biomarkers. Therefore, cardiovascular screening and follow-up of women with PCOS and their offspring and siblings are of utmost importance. Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Citation

Kim van der Ham, Yvonne V Louwers, Joop S E Laven. Cardiometabolic biomarkers in women with polycystic ovary syndrome. Fertility and sterility. 2022 May;117(5):887-896